Sanofi, GSK say Covid vaccine shows positive result
Sanofi, the French pharmacuetical giant is under criticism for a delay in COVID-19 vaccine
Here are the latest global developments regarding the coronavirus.
Sanofi has picked up Principia Bipharma for $3.7 billion.